TOP STORIES

• INTERVIEW Chugai to Execute Area-Based Strategy Centering on General Reps: Marketing Chief
  March 6, 2017

• BUSINESS Bioverativ Japan Now Up and Running, Set to Keep Double-Digit Growth: President
  March 3, 2017

• REGULATORY 7 Products Including iPS Cell-Derived Product Receive Sakigake Review Status in the Second Round of Designations
  March 2, 2017

• ORGANIZATION EFPIA Japan to Compile Policy Proposal on Pricing Reform by Early April: New Chair
  March 1, 2017

• INTERVIEW Daiichi Sankyo Espha Eyes 50 Billion Yen Sales in 2020 with AGs as Growth Engine
  February 28, 2017

• BUSINESS Daiichi Sankyo Takes Aim at Top Spot in Japan Ethical Drug Market: Next President
  February 27, 2017

• INTERVIEW Takeda’s Japan Biz “Going in Good Direction” towards 1st Underlying Sales Rise in 5 Years: Iwasaki
  February 24, 2017

• REGULATORY Overhaul Rules to Pick Comparator Meds in Similar Drug Pricing Method: Chuikyo Rep
  February 23, 2017

• REGULATORY CEFP Working Group to Go Full Throttle on Policy Guidelines Debate in March
  February 22, 2017

• REGULATORY New Formats for Package Inserts to Be Announced in April, Enforced from FY2019 with Transition Period: MHLW
  February 21, 2017

• ACADEMIA AMED Drafts Japan’s First Manual for Treatment of Mitochondrial Diseases
  February 20, 2017

• REGULATORY MHLW Advisory Panel to Review Shionogi’s ADHD Drug on March 2
  February 17, 2017

• TRENDS Daiichi Sankyo Espha Goes on AG Spree as It Wins Nod for 7 Major Brands
  February 16, 2017

• REGULATORY With Eye to June Listing, 24 Generic Makers Flock to Micardis Family, 15 to Abilify
  February 16, 2017

• BUSINESS Takeda, PRA to Launch JV in Japan to Take Over 140 Employees
  February 16, 2017

• BUSINESS Bristol-Myers Looks to Crack into Genotype 1 Hep C Market as Ximency Clears Resistance Mutation Hurdle
  February 15, 2017

• REGULATORY MHLW Mulls Administrative Penalties, Tighter Regulations after Counterfeit Harvoni Case
  February 14, 2017

• REGULATORY Japan’s First Guidance for Development of Cancer Immunotherapies Will Promote Development
  February 13, 2017

• BUSINESS Bayer Yakuhin Ramping Up Digital Transformation: New President
  February 10, 2017

• BUSINESS Harvoni No. 1 Drug in Japan in 2016 with Sales of 296 Billion Yen, More than Any Other Drug Over Past 10 Years: IMS Japan
  February 10, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 156
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• …
• Next ›
• 最終 »